Feeling welcomed: Creating space for Indigenous voices in brain and mental health research

Join us for the 2023 Brain Awareness Week Annual Neuroethics Distinguished Lecture featuring Dr. Melissa L. Perreault!

 

Tuesday, March 14, 2023
5:30 PM – 7:00 PM PDT
Bill Reid Gallery of Northwest Coast Art
639 Hornby Street, Vancouver, BC, V6C 2G3 (map)

Everyone is welcome! This public in-person event is free, but tickets are required.
Kindly RSVP here: https://ncbaw2023.eventbrite.ca 

Overview
Research on Indigenous communities has historically been conducted using a one-sided approach, with researchers having little knowledge of Indigenous culture, minimal concerns surrounding community needs or desires, and without giving back to the community. In this lecture intended for people from all backgrounds and professions, Dr. Melissa L. Perreault will discuss how this is the time to give Indigenous communities a voice in research on brain and mental health that is guided ethically and culturally.

Melissa L. Perreault, PhD
Dr. Melissa L. Perreault, PhD, is an Associate Professor and neuroscientist in the Department of Biomedical Sciences at the University of Guelph and a member of the College of New Scholars, Artists, and Scientists in the Royal Society of Canada. Dr. Perreault’s research is focused on the understanding of sex differences in the mechanisms that underly neuropsychiatric disorders, and on the identification of brain wave patterns that can be used as biomarkers to identify brain and mental health disorders.

Dr. Perreault is a citizen of the Métis Nation of Ontario, descended from the historic Métis Community of the Mattawa/Ottawa River. She has developed numerous Indigenous and equity, diversity, and inclusion initiatives at institutional, national, and international levels. As a member of the Indigenous Knowledge Holders Group for the Canadian Brain Research Strategy, she continues to strive towards inclusivity in neuroscience and Indigenous community research.

Brain Awareness Week
Brain Awareness Week is the global campaign to foster public enthusiasm and support for brain science. Every March, partners host imaginative activities in their communities that share the wonders of the brain and the impact brain science has on our everyday lives.

Advertisement

Hacking the mind: How technology is changing the way we view our brain and ourselves

Dr. Nir Lipsman (Assistant Professor, Division of Neurosurgery, Department of Surgery, University of Toronto) presented “Hacking the mind: How technology is changing the way we view our brain and ourselves” at the 2021 Brain Awareness Week – Annual Distinguished Neuroethics Lecture, held on March 16, 2021.

Overview:
As it advances, our relationship with brain technology will change. In this lecture, Dr. Nir Lipsman will discuss how our knowledge of brain circuitry, and how it can go wrong, has informed our understanding of human behaviour. We will then discuss the implications of more sophisticated, precise and less intrusive brain technology, on that relationship, and what it could all mean for the next generation of brain therapy and beyond…

Bio:
Nir Lipsman MD, PhD, FRCSC, is a neurosurgeon and scientist at Sunnybrook Health Sciences Centre and an Assistant Professor of Surgery at the University of Toronto. He completed his undergraduate degree at the University of Toronto followed by a medical degree at Queen’s University, and a neurosurgical residency at the University of Toronto. During his residency, Dr. Lipsman completed his PhD investigating novel neuromodulation strategies in patients with treatment-resistant psychiatric and neurologic conditions. He is currently the Director of Sunnybrook’s Harquail Center for Neuromodulation, and the Clinical Director of Sunnybrook’s Focused Ultrasound Centre of Excellence.

Dr. Lipsman has helped develop several clinical trials of MR-guided focused ultrasound (FUS) in novel indications, including among the world’s first experience of FUS in essential tremor, obsessive-compulsive disorder, major depression and chronic pain, as well as the first randomized control trial of FUS in tremor. He has led the world’s first application of FUS-mediated blood brain barrier (BBB) opening in Alzheimer’s Disease, and helped develop the first applications in primary and secondary brain tumors and ALS. He has published over 100 peer-reviewed papers and book chapters, including in The Lancet, Lancet Neurology, Lancet Psychiatry, New England Journal of Medicine, and Neuron.

Dr. Lipsman also has a strong interest in the broader clinical and ethical implications of neuromodulation, and has been closely involved in the development of international guidelines for the use of surgery in psychiatric disease. In collaboration with Drs. Judy Illes and Pat McDonald at UBC, he helped found the Pan Canadian Neurotechnology Ethics Consortium (PCNEC), bringing together experts in neuromodulation and ethics, to identify and tackle the most pressing ethical questions in the field.